Affiliations 

  • 1 Institute of Ocean and Earth Sciences, Advanced Studies Complex, Universiti Malaya, 50603 Wilayah Persekutuan Kuala Lumpur, Malaysia
  • 2 School of Health Sciences, Nutrition and Dietetics Program, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan Malaysia
  • 3 Department of Pharmaceutical Sciences, Campus C-UNAIR, Faculty of Pharmacy, Universitas Airlangga, East Java, Surabaya, 60115 Indonesia
  • 4 School of Pharmacy, College of Medicine, National Cheng Kung University, 70101 Tainan, Taiwan
  • 5 Regional Innovation Center, Saga University, 1, Honjo, Saga, 840-8502 Japan
  • 6 Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Wilayah Persekutuan Kuala Lumpur, Malaysia
  • 7 Faculty of Applied Sciences, UCSI University, 56000 Wilayah Persekutuan Kuala Lumpur, Malaysia
3 Biotech, 2023 Oct;13(10):337.
PMID: 37701628 DOI: 10.1007/s13205-023-03725-6

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease that causes deterioration in intelligence and psychological activities. Yet, till today, no cure is available for AD. The marine environment is an important sink of bioactive compounds with neuroprotective potential with reduced adverse effects. Recently, we collected the red algae Laurencia snackeyi from Terumbu Island, Malaysia which is known to be rich in halogenated metabolites making it the most sought-after red algae for pharmaceutical studies. The red alga was identified based on basic morphological characteristics, microscopic observation and chemical data from literature. The purplish-brown algae was confirmed a new record. In Malaysia, this species is poorly documented in Peninsular Malaysia as compared to its eastern continent Borneo. Thus, this study intended to investigate the diversity of secondary metabolites present in the alga and its cholinesterase inhibiting potential for AD. The extract inhibited both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with IC50 values of  14.45 ± 0.34 μg mL-1 and 39.59 ± 0.24 μg mL-1, respectively. Subsequently, we isolated the synderanes, palisadin A (1), aplysistatin (2) and 5-acetoxypalisadin B (3) that was not exhibit potential. Mass spectrometry analysis detected at total of 33 additional metabolites. The computational aided molecular docking using the AChE and BChE receptors on all metabolites shortlisted 5,8,11,14-eicosatetraynoic acid (31) and 15-hydroxy-1-[2-(hydroxymethyl)-1-piperidinyl]prost-13-ene-1,9-dione (42) with best inhibitory properties, respectively with the lowest optimal combination of S-score and RMSD values. This study shows the unexplored potential of marine natural resources, however, obtaining sufficient biomass for detailed investigation is an uphill task. Regardless, there is a lot of potential for future prospects with a wide range of marine natural resources to study and the incorporation of synthetic chemistry, in vivo studies in experimental design.

SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-023-03725-6.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.